Yahoo Web Search

Search results

1. • 

     Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting

     Char-Koosta News· 1 day ago

     SAN FRANCISCO and SUZHOU, China, April 24, 2024 /PRNewswire/ -- Innovent Biologics, Inc....

2. • 

     How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?

     Zacks via Yahoo Finance· 3 days ago

     Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...

3. • Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML

     Morningstar· 4 days ago

     Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that its ...

4. • BeiGene (NASDAQ:BGNE) Trading Down 2.4%

     ETF DAILY NEWS· 5 days ago

     BeiGene, Ltd. (NASDAQ:BGNE – Get Free Report)’s stock price dropped 2.4% during trading on Friday . The company traded as low as $126.97 and last traded at $128.77. Approximately 17,319 shares ...

5. • Exelixis, Inc. (NASDAQ:EXEL) Shares Acquired by Mirae Asset Global Investments Co. Ltd.

     ETF DAILY NEWS· 23 hours ago

     Mirae Asset Global Investments Co. Ltd. grew its holdings in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 5.7% during the 4th quarter, according to its most recent Form 13F filing with the ...

6. • Small Business - Cordele Dispatch | Cordele Dispatch

     Cordele Dispatch· 2 days ago

     New York, USA, April 24, 2024 (GLOBE NEWSWIRE) -- HDAC Inhibitor Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight According to DelveInsight’s analysis, the growth of the HDAC inhibitors market is expected

7. • Analysts Set BeiGene, Ltd. (NASDAQ:BGNE) PT at $251.70

     ETF DAILY NEWS· 4 days ago

     BeiGene, Ltd. (NASDAQ:BGNE – Get Free Report) has been given an average recommendation of “Moderate Buy” by the nine ratings firms that are currently covering the stock, MarketBeat Ratings reports ...

8. • Small Business - Shelby County Reporter | Shelby County Reporter

     The Shelby County Reporter· 24 hours ago

     Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting PR Newswire SAN FRANCISCO and SUZHOU, China, April 24, 2024 SAN FRANCISCO and SUZHOU, China, April 24, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("

9. • Nisa Investment Advisors LLC Has $29,000 Position in Janux Therapeutics, Inc. (NASDAQ:JANX)

     ETF DAILY NEWS· 3 days ago

     Nisa Investment Advisors LLC lifted its position in Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) by 10,740.0% during the fourth quarter, according to its most recent 13F filing with ...

10. • Zacks Research Analysts Lower Earnings Estimates for Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

      ETF DAILY NEWS· 7 days ago

      Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) – Analysts at Zacks Research cut their FY2024 earnings estimates for Iovance Biotherapeutics in a note issued to investors on Monday ...